Vor Biopharma Inc.

8-K Director or officer change Jul 7, 2026 8-K Shareholder vote results Jun 12, 2026 8-K Regulation FD disclosure Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Director or officer change Jan 2, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Dec 18, 2025 8-K Director or officer change Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Other events Nov 12, 2025 8-K Director or officer change; Regulation FD disclosure Nov 3, 2025 8-K Regulation FD disclosure Oct 28, 2025 8-K Modified rights of security holders; Other events Sep 17, 2025 8-K Regulation FD disclosure Sep 2, 2025 8-K Director or officer change Aug 27, 2025 8-K Director or officer change; Shareholder vote results; Other events Aug 27, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Director or officer change; Regulation FD disclosure Jul 22, 2025 8-K Director or officer change; Regulation FD disclosure Jul 10, 2025 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Jun 26, 2025 8-K Amended charter or bylaws; Shareholder vote results May 23, 2025 8-K Director or officer change May 20, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Exit or disposal costs; Director or officer change; Other events May 8, 2025 8-K Delisting notice or listing-rule failure Apr 25, 2025 8-K Director or officer change Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Director or officer change Feb 6, 2025 8-K Director or officer change; Regulation FD disclosure Jan 8, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Dec 27, 2024 8-K Regulation FD disclosure; Other events Dec 9, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Director or officer change; Regulation FD disclosure Sep 30, 2024 8-K Regulation FD disclosure; Other events Sep 5, 2024 8-K Delisting notice or listing-rule failure Aug 30, 2024 10-Q/A Quarter ended 2024-03-31 Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Director or officer change Jun 10, 2024